Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1739-1757
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1739
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1739
Variable | Overall survival | Disease-free survival | ||||||
Uni-P | Multi-P | HR | 95%CI | Uni-P | Multi-P | HR | 95%CI | |
Gender | ||||||||
Male vs female | 0.08 | 0.450 | ||||||
Age (yr) | ||||||||
< 55 vs ≥ 55 | 0.348 | 0.353 | ||||||
Tumor location | ||||||||
Upper vs middle vs lower | 0.647 | 0.385 | ||||||
Tumor number | ||||||||
Single vs multiple | 0.200 | 0.227 | ||||||
Tumor size (cm) | ||||||||
< 5.5 vs ≥ 5 | 0.282 | 0.124 | ||||||
Gross classification | ||||||||
Superficial vs polypoid vs ulcerative and others | 0.04 | 0.249 | 0.007 | 0.893 | ||||
Depth of invasion | ||||||||
T1a vs T1b vs T2 and T3 and T4 | 0.001 | 0.005 | 1.70 | 1.17-2.47 | 0.02 | 0.02 | 1.93 | 1.09-3.42 |
LNM | ||||||||
No vs yes | < 0.001 | 0.009 | 1.78 | 1.15-2.74 | 0.07 | |||
pTNM stage | ||||||||
I vs II vs III and IV | < 0.001 | 0.349 | 0.02 | 0.540 | ||||
Treatment | ||||||||
Surgery vs surgery plus adjuvant therapy | 0.433 | 0.02 | 0.698 |
- Citation: Zhou SL, Zhang LQ, Zhao XK, Wu Y, Liu QY, Li B, Wang JJ, Zhao RJ, Wang XJ, Chen Y, Wang LD, Kong LF. Clinicopathological characterization of ten patients with primary malignant melanoma of the esophagus and literature review. World J Gastrointest Oncol 2022; 14(9): 1739-1757
- URL: https://www.wjgnet.com/1948-5204/full/v14/i9/1739.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i9.1739